(Total Views: 183)
Posted On: 03/31/2019 8:03:53 PM
Post# of 154479

Re: ClosetInvestor #1528
RP did some comparisons before signing away his Intellectual Property for CYDY shares. In those Pro 140 performed better than maraviroc.
He must have been convinced with his research that this will also carry over in human trials.
He must have been convinced with his research that this will also carry over in human trials.


